Msteller

U.S. Representatives Cliff Bentz and Jared Golden have reintroduced the Patients’ Right to Know Their Medication Act (HR 5133) to ensure all Americans receive printed medication information with prescriptions. This bipartisan bill aims to improve patient safety, particularly in rural areas with limited access to internet and pharmacists, by mandating FDA-approved Patient Medication Information.

The Seattle Times recently highlighted the impact of drugstore closures in the Pacific Northwest, focusing on Bartell Drugs. The Pharmaceutical Printed Literature Association warns that a proposed FDA regulation could worsen pharmacy access, increasing burdens on pharmacists and risking patient safety by shifting the responsibility for medication information to them.

The Pharmaceutical Printed Literature Association (PPLA) is advocating for the retention of printed Prescribing Information (PI) and Patient Medication Information (PMI) amidst proposed FDA rules that could limit access. They emphasize that printed materials are vital for rural Americans lacking digital access, urging the Trump administration to protect these resources to ensure medication safety and effective management.

The Pharmaceutical Printed Literature Association (PPLA) urges Dr. Marty Makary to prioritize patient safety by reversing harmful FDA regulations on printed medication information if confirmed as commissioner. The proposed rules threaten crucial printed instructions for patients and pharmacists, compromising care and safety. PPLA advocates for accessible medication literature to enhance patient involvement.

Following President Trump’s inauguration, PPLA Chairman Dave Joesten urged nominees Robert F. Kennedy Jr. and Dr. Marty Makary to rescind proposed FDA rules that would limit printed Prescribing and Patient Medication Information. These rules threaten patient safety, particularly for vulnerable populations, while a bipartisan coalition supports legislation for accessible printed information.

On January 12th, National Pharmacist Day highlighted the crucial role pharmacists play amid a wave of pharmacy closures impacting millions of Americans. With 7,000 pharmacies closing since 2019, the FDA’s proposed rule on Patient Medication Information could exacerbate the crisis by increasing costs and workloads, threatening patient access to vital medication guidance.

Since 2019, over 7,000 pharmacies have closed in the U.S., creating pharmacy deserts. This crisis emphasizes the need for accessible printed Patient Medication Information (PMI) for safe medication use. The FDA’s proposed rule limiting PMI access may exacerbate the issue, prompting bipartisan support for the Patients’ Right to Know Their Medication Act to ensure patients receive vital information.

The Pharmaceutical Printed Literature Association’s survey shows that 93% of Rx consumers prefer cognitively-backed printed patient medication information (PMI) over the FDA’s proposed format. Most respondents find the enhanced design easier to understand and worry about accessing information electronically. PPLA aims to collaborate with the FDA for improved PMI standards.

Walgreens is closing 1,200 stores, worsening the pharmacy desert crisis in the U.S. This situation emphasizes the need for accessible Patient Medication Information (PMI) for safe medication use. A bipartisan bill aims to guarantee printed PMI with prescriptions, advocating for patient safety amidst pharmacy access challenges. PPLA supports these efforts to enhance health communication.

The Pharmaceutical Printed Literature Association (PPLA) is advocating for printed Patient Medication Information (PMI) to ensure access during natural disasters like Hurricanes Helene and Milton, which disrupted digital access. A bipartisan bill, the Patients’ Right to Know Their Medication Act, supports this initiative for patient safety and informed medication use.